Stay updated on Repurposed Medications Clinical Trial
Sign up to get notified when there's something new on the Repurposed Medications Clinical Trial page.
Latest updates to the Repurposed Medications Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe ACTIV-6 record now displays details of the completed COVID-19 trial, including its study design, medication arms, eligibility criteria, locations, and publications. It also includes individual participant data sharing information and a study protocol document.SummaryDifference100%
- Check14 days agoChange DetectedThe footer revision identifier changes from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.SummaryDifference0.3%
- Check21 days agoChange DetectedA site-wide NIH banner announces a transition from the term “Artificial Intelligence” to “Super Intelligence” under an executive order.SummaryDifference1%
- Check28 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changes from v3.7.1 to v3.7.2 on the error page.SummaryDifference0.2%
- Check35 days agoChange DetectedThe ClinicalTrials.gov error page’s footer revision identifier changes from v3.7.0 to v3.7.1, while the study record remains inaccessible.SummaryDifference0.2%
- Check56 days agoChange DetectedThe study detail page now displays a 403 Forbidden error, making the previous content inaccessible. This indicates an access issue that affects the main purpose of the page.SummaryDifference19%
Stay in the know with updates to Repurposed Medications Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Repurposed Medications Clinical Trial page.